Ternalys Therapeutics, Inc.
Chapel Hill, NC
- UEI
- T7EMGFNJVB53
- CAGE
- 98SD0
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2128 N Lakeshore Dr, Chapel Hill, NC 27514, USA
- Website
- ternalys.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Optimizing composition and delivery of a novel RNA therapy for glioblastoma | National Cancer Institute (NIH) | $551,532 |
Quick answers
Is Ternalys Therapeutics, Inc. registered in SAM.gov?
Yes. Ternalys Therapeutics, Inc.'s SAM.gov registration is active through August 2, 2027.
What is Ternalys Therapeutics, Inc.'s most recent federal award?
Ternalys Therapeutics, Inc.'s most recent federal grant award is Optimizing composition and delivery of a novel RNA therapy for glioblastoma (R41CA278074), from National Cancer Institute (NIH), on September 7, 2022.
On GovTribe
See Ternalys Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors